Table 2.
Elucidating various drugs used to treat SARS-CoV, MERS-CoV, and SARS-CoV-2, along with their mechanism of action and adverse effects.
S. no. | Drug | Effective against | Mechanism of action | Adverse effects | References |
---|---|---|---|---|---|
1. | Ribavirin | SARS-CoV | Anti-viral nucleoside analog – inhibits the viral genomic replication | Anemia, hypocalcemia, hypomagnesemia, developed the risk of teratogenicity and bradycardia | [118]. |
2. | Lopinavir | SARS-CoV | Protease inhibitors | Diarrhea, nausea, vomiting, headache | [122] |
3. | Ritonavir | SARS-CoV | Protease inhibitors | Diarrhea, nausea, vomiting, headache | [122] |
4. | Methylprednisolone | SARS-CoV | Anti-inflammatory effect | The onset of diabetes, avascular necrosis, osteoporosis. | [132,133] |
5. | Corticosteroids | SARS-CoV | Inhibits pro-inflammatory effects | Aspergillosis and fungal superinfection | [49,134] |
6. | Methylprednisolone (0.5–1 mg/kg) followed by hydrocortisone (100 mg/8 h) and pulse doses of methylprednisolone (0.5 g for 3 d) | Lung diseases | – | – | [124] |
7. | Convalescent plasma | SARS-CoV, MERS-CoV, SARS-CoV-2 | Adaptive or passive immune response | – | [135,139] |
8. | Lopinavir/ritonavir | MERS-CoV, SARS-CoV-2 | Not effective against MERS, anti-viral therapy for pneumonia caused by SARS-CoV-2 | Diarrhea, nausea, vomiting, headache | [140] |
9. | Pegylated interferon-α | Hepatitis-C, MERS-CoV | Inhibits DNA synthesis | Diarrhea, nausea, vomiting, headache | [140] |
10. | Lopinavir/ritonavir and IFN-β | MERS-CoV | Improves pulmonary, reduce viral load, and necrosis in lungs and extrapulmonary tissues | Diarrhea, nausea, vomiting, headache | [143,144] |
11. | Hydroxychloroquine | SARS-CoV-2, Malaria | Blocks maturation of endosome, maturation and its function by inhibiting the release of virions in the infected cell | Diarrhea, nausea, vomiting, headache, dizziness | [112] |